189 related articles for article (PubMed ID: 27725229)
1. In-vitro activity of solithromycin against anaerobic bacteria from the normal intestinal microbiota.
Weintraub A; Rashid MU; Nord CE
Anaerobe; 2016 Dec; 42():119-122. PubMed ID: 27725229
[TBL] [Abstract][Full Text] [Related]
2. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
Putnam SD; Castanheira M; Moet GJ; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of solithromycin and levofloxacin against a murine pneumonia mixed-infection model caused by Streptococcus pneumoniae and anaerobic bacteria.
Kato H; Yamagishi Y; Hagihara M; Yokoyama Y; Suematsu H; Asai N; Koizumi Y; Mikamo H
J Infect Chemother; 2019 Apr; 25(4):311-313. PubMed ID: 30287186
[TBL] [Abstract][Full Text] [Related]
4. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci.
Putnam SD; Sader HS; Farrell DJ; Biedenbach DJ; Castanheira M
Int J Antimicrob Agents; 2011 Jan; 37(1):39-45. PubMed ID: 21075602
[TBL] [Abstract][Full Text] [Related]
6. Ecological Effect of Solithromycin on Normal Human Oropharyngeal and Intestinal Microbiota.
Rashid MU; Rosenborg S; Panagiotidis G; Holm J; Söderberg Löfdal K; Weintraub A; Nord CE
Antimicrob Agents Chemother; 2016 Jul; 60(7):4244-51. PubMed ID: 27139483
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections.
Hawser S; Morrissey I; Lemos B; Keedy K; Fernandes P
Int J Antimicrob Agents; 2017 Jul; 50(1):17-22. PubMed ID: 28483717
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin.
Furfaro LL; Spiller OB; Keelan JA; Payne MS
Int J Antimicrob Agents; 2015 Sep; 46(3):319-24. PubMed ID: 26141231
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections.
Odou MF; Muller C; Calvet L; Dubreuil L
J Antimicrob Chemother; 2007 Apr; 59(4):646-51. PubMed ID: 17350985
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility pattern of oral gram negative anaerobes from Indian subjects.
Bhat KG; Ingalagi P; Patil S; Patil S; Pattar G
Anaerobe; 2021 Aug; 70():102367. PubMed ID: 33872790
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials.
Tomás I; Tomás M; Alvarez M; Velasco D; Potel C; Limeres J; Diz P
Oral Microbiol Immunol; 2007 Oct; 22(5):298-303. PubMed ID: 17803626
[TBL] [Abstract][Full Text] [Related]
12. Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole.
Dubreuil LJ; Mahieux S; Neut C; Miossec C; Pace J
Int J Antimicrob Agents; 2012 Jun; 39(6):500-4. PubMed ID: 22521766
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria.
Hu J; Zhang J; Wu S; Zhu D; Huang H; Chen Y; Yang Y; Zhang Y
Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis.
Werner H; Heizmann WR; Höflsauer M
Infection; 1991; 19(5):377-9. PubMed ID: 1800380
[TBL] [Abstract][Full Text] [Related]
15. Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents.
Ednie LM; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 2002 Jul; 50(1):101-5. PubMed ID: 12096013
[TBL] [Abstract][Full Text] [Related]
16. Human serum activity of telithromycin, azithromycin and amoxicillin/clavulanate against common aerobic and anaerobic respiratory pathogens.
Stein GE; Schooley S; Tyrrell KL; Citron DM; Goldstein EJ
Int J Antimicrob Agents; 2007 Jan; 29(1):39-43. PubMed ID: 17189093
[TBL] [Abstract][Full Text] [Related]
17. Low antibiotic resistance among anaerobic Gram-negative bacteria in periodontitis 5 years following metronidazole therapy.
Dahlen G; Preus HR
Anaerobe; 2017 Feb; 43():94-98. PubMed ID: 27988390
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria.
Citron DM; Tyrrell KL; Merriam CV; Goldstein EJ
Antimicrob Agents Chemother; 2010 Apr; 54(4):1627-32. PubMed ID: 20100877
[TBL] [Abstract][Full Text] [Related]
19. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
[TBL] [Abstract][Full Text] [Related]
20. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
